AULYX
Price
$102.46
Change
+$1.07 (+1.06%)
Updated
Dec 20 closing price
VIGAX
Price
$214.81
Change
+$2.25 (+1.06%)
Updated
Dec 20 closing price
Ad is loading...

AULYX vs VIGAX

Header iconAULYX vs VIGAX Comparison
Open Charts AULYX vs VIGAXBanner chart's image
American Century Ultra® Y
Price$102.46
Change+$1.07 (+1.06%)
VolumeN/A
CapitalizationN/A
Vanguard Growth Index Admiral
Price$214.81
Change+$2.25 (+1.06%)
VolumeN/A
CapitalizationN/A
AULYX vs VIGAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AULYX vs. VIGAX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AULYX is a StrongBuy and VIGAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VIGAX has more cash in the bank: 282B vs. AULYX (26.9B). VIGAX pays higher dividends than AULYX: VIGAX (0.53) vs AULYX (0.00). AULYX was incepted earlier than VIGAX: AULYX (8 years) vs VIGAX (24 years). AULYX is a more actively managed with annual turnover of: 20.00 vs. VIGAX (5.00). AULYX has a lower initial minimum investment than VIGAX: AULYX (0) vs VIGAX (3000). VIGAX annual gain was more profitable for investors over the last year : 34.38 vs. AULYX (27.99). VIGAX return over 5 years is better than : 129.78 vs. AULYX (88.97).
AULYXVIGAXAULYX / VIGAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years24 years-
Gain YTD28.02734.26682%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets26.9B282B10%
Annual Yield % from dividends0.000.53-
Returns for 1 year27.9934.3881%
Returns for 3 years12.9232.7839%
Returns for 5 years88.97129.7869%
Returns for 10 yearsN/A298.54-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TOP1.320.04
+3.13%
TOP Financial Group Limited
CALX35.360.69
+1.99%
CALIX
ONTO167.25-0.25
-0.15%
Onto Innovation
EBF20.68-0.35
-1.66%
Ennis
ZVSA1.14-0.10
-8.06%
ZyVersa Therapeutics